GT Medical Technologies, Inc. is an Arizona-based medical device company focused on improving the lives of patients with brain tumors. Its innovative approach combines a conformable collagen matrix with brachytherapy (radiation) seeds. This product has the potential to revolutionize treatment for 176,000 patients/year in the US alone. Since its establishment in 2017, the company has treated 1000+ patients. The latest investment of $218.02KVenture Round was secured on 29 April 2024. With its mission to enhance the quality of life for brain tumor patients, GT Medical Technologies is making significant strides in the Health Care industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $218.02K | - | 29 Apr 2024 | |
Series C | $45.00M | 5 | MVM Life Science Partners | 23 Mar 2023 |
Series B | $16.00M | 3 | MVM Life Science Partners | 23 Nov 2020 |
Series A | $10.00M | 2 | 31 Jan 2019 | |
Seed Round | Unknown | 1 | 12 Jun 2018 |
No recent news or press coverage available for GT Medical Technologies, Inc..